Replimune (REPL) Total Non-Current Liabilities (2018 - 2026)
Replimune (REPL) recorded Total Non-Current Liabilities of $146.35 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 11.0% from $131.85 million a year earlier but down 11.7% from the prior quarter.
Powered by 
Analysis
Replimune (REPL) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Replimune reported Total Non-Current Liabilities of $165.77 million, up 23.2% from FY2025.
- Annual Total Non-Current Liabilities has increased for four straight fiscal years, with a four-year compound annual growth rate of 35.0% (FY2022 to FY2026).
- Across earlier fiscal years, Total Non-Current Liabilities came in at $134.54 million in FY2025 (+19.7%), $112.43 million in FY2024 (+23.8%), $90.83 million in FY2023 (+81.8%) and $49.96 million in FY2022.
- Quarterly Total Non-Current Liabilities has ranged from $49.96 million in fiscal Q4 2022 to $165.77 million in fiscal Q4 2026 over the past five years.
- On a year-over-year basis, Total Non-Current Liabilities has increased for ten consecutive quarters, with growth averaging 14.3% over the last eight quarters.
- Over the past five years, the year-over-year growth in Total Non-Current Liabilities ranged from 2.0% (fiscal Q3 2026) to 81.8% (fiscal Q4 2023).
- Per Business Quant, the preceding three fiscal quarters came in at $165.77 million (Q4 2026), $122.36 million (Q3 2026) and $125.17 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 5.92 Bn |
| 10 | Replimune | 1.05 Bn | 1.05 Bn | - | 146.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 146.35 Mn |
| Mar 31, 2026 | 165.77 Mn |
| Dec 31, 2025 | 122.36 Mn |
| Sep 30, 2025 | 125.17 Mn |
| Jun 30, 2025 | 131.85 Mn |
| Mar 31, 2025 | 134.54 Mn |
| Dec 31, 2024 | 119.99 Mn |
| Sep 30, 2024 | 115.96 Mn |
| Jun 30, 2024 | 107.73 Mn |
| Mar 31, 2024 | 112.43 Mn |
| Dec 31, 2023 | 110.60 Mn |
| Sep 30, 2023 | 96.75 Mn |
| Jun 30, 2023 | 89.28 Mn |
| Mar 31, 2023 | 90.83 Mn |
| Mar 31, 2022 | 49.96 Mn |
| Mar 31, 2019 | 16.45 Mn |
| Dec 31, 2018 | 8.78 Mn |
| Sep 30, 2018 | 3.74 Mn |
| Jun 30, 2018 | 90.90 Mn |
| Mar 31, 2018 | 91.58 Mn |
API Access
Replimune Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();